GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
GOT Applied As Neoadjuvant Regimen for Patients of Resectable ICC with High-risk Factors of Recurrence	Neoplasms by Histologic Type, adenocarcinoma, carcinoma, cholangiocarcinoma, epithelial neoplasm, intrahepatic cholangiocarcinoma, neoplasm	Recruiting	Phase 2	2025-02-11		NCT05557578

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Zhejiang Cancer Hospital	142

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
1# Banshan East Rd. Zhejiang cancer hospital	Hangzhou	China	2
Jia Wu	Hanzhou	China	1

Clinical trials